“I want to say thank you to the Drs and team for getting me in on short notice for an emergency appointment and a shout out to Laura for keeping me updated on my appointment and calling me back in a timely manner thank you all.”
Dark Floaters That Look Like Smoke or Clouds
When Dark Floaters Are a Retinal Emergency
Not every floater requires the same level of urgency, but dark or smoke-like floaters that appear suddenly are almost always a warning sign that should not be ignored. Knowing which symptoms require same-day care can make a meaningful difference in your outcome.
Seek same-day care if you notice any of the following. A sudden appearance of dark, smoke-like, or cloud-like floaters is the primary warning sign. A reddish tint or dark haze rapidly spreading across your vision suggests active bleeding. New floaters accompanied by flashes of light raise concern for a retinal tear as the source of bleeding.
- Sudden dark, smoky, or cloud-like floaters
- A reddish tint or spreading dark haze across your vision
- New floaters paired with flashes of light
- A noticeable drop in vision along with new dark floaters
- A shadow or dark curtain creeping in from the side of your vision
A shadow in your peripheral vision alongside dark floaters may mean the retina has already detached, which requires urgent surgical repair.
Certain patients face a higher risk of serious complications from vitreous hemorrhage. People with diabetes who develop sudden dark floaters or a visual haze should seek urgent evaluation, as this often represents bleeding from proliferative diabetic retinopathy. Patients with a history of retinal vein occlusion who notice new dark floaters may be experiencing recurrent bleeding from abnormal vessels.
People with sickle cell disease and new dark floaters need prompt assessment for sickle cell retinopathy-related hemorrhage. Patients on blood-thinning medications who develop this symptom should be evaluated promptly, and those medications should not be stopped without consulting the prescribing physician first.
Small, transparent, web-like floaters that have been present and unchanged for months or years, and have already been evaluated, are typically caused by normal vitreous degeneration. They are generally benign and do not suggest bleeding inside the eye.
However, any change from transparent to dark or dense floaters, a sudden increase in the number or size of floaters, or any new visual symptom accompanying existing floaters should prompt a new evaluation by your retina specialist. The distinction between old benign floaters and new dark ones matters greatly.
How Your Retina Specialist Evaluates This Symptom
A thorough evaluation is essential when dark floaters suggest vitreous hemorrhage. Your retina specialist will use a combination of clinical examination and advanced imaging to determine the cause and severity of the bleeding, even when blood limits the view of the retina.
Your retina specialist will dilate your pupils to examine the vitreous, retina, and optic nerve in detail. The amount and density of blood in the vitreous is assessed, along with any visible source of bleeding. When a clear view of the retina is possible, the entire retinal surface is examined for tears, neovascularization, vein occlusion, macroaneurysm, or other abnormalities.
How much the blood obscures the retinal view is an important factor in deciding what imaging and treatment steps come next.
When blood is dense enough to block a direct view of the retina, B-scan ultrasonography becomes essential. This imaging uses sound waves to visualize the structures behind the blood, including the retina and vitreous. It can detect retinal detachment, tears, tumors, and vitreous membranes that would otherwise be invisible.
Serial ultrasound exams may be performed at regular intervals to monitor the retina while the hemorrhage clears over time. Our team uses in-office B-scan ultrasound as part of our complete retinal imaging capabilities.
When the hemorrhage is mild enough to allow imaging, optical coherence tomography (OCT) provides detailed cross-sectional images of the retinal layers. OCT can detect macular edema (swelling in the central retina), traction, or other structural changes that affect treatment decisions. OCT angiography can map the retinal blood vessels and identify areas of abnormal new vessel growth without dye injection.
Fluorescein angiography, which uses an injected dye to highlight retinal circulation, may be performed once the hemorrhage has cleared enough to allow a detailed view of the vascular structure of the retina.
Depending on the suspected cause, your retina specialist may recommend blood tests and coordination with your primary care provider. For patients without a known diagnosis of diabetes, blood sugar and hemoglobin A1c testing can screen for undiagnosed disease. Blood pressure assessment is important when a macroaneurysm or hypertensive retinopathy is suspected.
Coagulation studies may be relevant for patients with recurrent hemorrhage or those on anticoagulant therapy. Identifying and managing systemic risk factors is an important part of preventing future bleeding episodes.
Conditions That May Be Discovered
A thorough evaluation often reveals the specific condition responsible for the vitreous hemorrhage. Each finding has its own treatment approach, and identifying it early improves the chance of preserving vision.
A retinal tear is one of the most critical findings to identify, because an untreated tear can allow fluid to seep beneath the retina and cause a retinal detachment. When vitreous hemorrhage is present alongside a PVD, the likelihood of a retinal tear is high. Prompt treatment with laser photocoagulation or cryotherapy (a freezing probe treatment) seals the tear and prevents detachment.
Treating a retinal tear early can prevent the need for far more complex retinal detachment surgery later.
PDR is diagnosed when abnormal new blood vessels are identified on the retinal surface or optic disc in a patient with diabetic retinopathy. Treatment is aimed at causing these vessels to regress and preventing further bleeding. This typically involves a combination of anti-VEGF injections, panretinal photocoagulation (a laser treatment applied across the peripheral retina to reduce the stimulus for new vessel growth), and vitrectomy surgery when needed.
Our team tailors the combination and sequence of treatments to each patient's retinal findings and overall health.
Retinal vein occlusion may be identified by the pattern of hemorrhage and vascular changes visible on examination or imaging. Treatment addresses both the resulting macular edema and the risk of abnormal vessel growth that can cause recurrent bleeding. Anti-VEGF injections are the primary treatment for macular edema associated with vein occlusion, and laser treatment may be used when neovascularization (abnormal new vessel growth) develops.
If ultrasound or clinical examination reveals that the retina has separated from the underlying tissue (retinal detachment), surgical repair is necessary. The type of surgery depends on the location and extent of the detachment. Options may include pars plana vitrectomy, scleral buckling (a procedure that indents the outer wall of the eye to support the retina), pneumatic retinopexy (injection of a gas bubble to push the retina back into place), or a combination of these approaches.
Early detection of a detachment through ultrasound monitoring during vitreous hemorrhage is critical for timely intervention and the best possible visual recovery.
Treatment Options for Vitreous Hemorrhage
Treatment depends entirely on the underlying cause and severity of the hemorrhage. Some cases can be observed and monitored, while others require prompt intervention. Your retina specialist will guide you through the appropriate plan based on your specific findings.
When the retina is intact and no active or threatening cause of bleeding is identified, mild vitreous hemorrhage may be managed with careful observation. Blood is gradually absorbed by the eye over weeks to months, and dark floaters typically become lighter and less noticeable as this happens.
During observation, your retina specialist will monitor the retina with periodic examinations and ultrasound as needed. Elevating the head during sleep and avoiding strenuous activity may help blood settle toward the bottom of the eye, clearing the central visual field more quickly.
When a retinal tear is identified, laser photocoagulation creates a ring of controlled burns around the tear. These burns form scar tissue that seals the tear and prevents fluid from passing through it. Cryotherapy uses a freezing probe applied to the outer surface of the eye to achieve the same result.
Both treatments are effective at preventing retinal detachment when applied promptly. If hemorrhage is too dense for laser at the time of diagnosis, close monitoring with ultrasound continues until the view clears enough for treatment to be safely applied.
For vitreous hemorrhage caused by proliferative diabetic retinopathy, anti-VEGF (anti-vascular endothelial growth factor) injections are a cornerstone of treatment. These medications, which include aflibercept (Eylea), ranibizumab (Lucentis), bevacizumab (Avastin, used off-label), and faricimab (Vabysmo), help cause the abnormal blood vessels to regress and reduce the risk of further bleeding.
Panretinal photocoagulation, a laser treatment applied to the peripheral retina, reduces the underlying stimulus for new vessel growth. Your retina specialist will determine the best combination and timing of these treatments based on the stage and severity of your diabetic retinal disease.
Vitrectomy may be recommended when vitreous hemorrhage does not clear within a reasonable period, when the retina cannot be adequately evaluated or treated through the blood, or when retinal detachment or persistent abnormal vessels require direct surgical attention. During vitrectomy, the blood-filled vitreous gel is carefully removed and replaced with a clear saline solution, restoring visibility inside the eye.
The surgeon can then directly visualize and treat the retinal surface, addressing tears, detachment, or neovascularization during the same procedure. Current evidence supports earlier consideration of vitrectomy for hemorrhage from proliferative diabetic retinopathy, as prompt surgery has been associated with better visual outcomes in many patients.
Frequently Asked Questions
These answers address common questions patients ask about dark, smoke-like floaters that go beyond what is covered in the sections above.
Mild vitreous hemorrhage can clear on its own as the blood is gradually absorbed over weeks to months. As this happens, the dark smoky appearance typically becomes lighter and less noticeable. However, clearing of the blood does not mean the underlying cause has resolved. Your retina specialist will continue to monitor the retina and treat any responsible condition, such as a retinal tear or neovascularization, to prevent recurrent bleeding or more serious complications.
Same-day evaluation is recommended whenever dark, smoke-like, or cloud-like floaters appear suddenly. If you also notice flashes of light, a dark curtain in your peripheral vision, or a sudden drop in visual clarity, the urgency is even greater, as these signs can indicate a retinal tear or detachment. If you are unable to reach your retina specialist on the same day, an emergency room with an on-call ophthalmologist can perform an initial evaluation to rule out the most urgent conditions while you arrange a follow-up appointment.
Dark or smoky floaters in a person with diabetes should always raise concern for proliferative diabetic retinopathy, a stage of diabetic eye disease in which abnormal blood vessels grow on the retinal surface and are prone to bleeding. This does not mean the outlook is hopeless, as effective treatments including anti-VEGF injections and laser are available when the condition is identified and treated promptly. Regular dilated eye examinations, good blood sugar management, and blood pressure control all help reduce the risk of reaching this stage, and early-stage disease can often be treated before hemorrhage occurs.
In the vast majority of cases, dark smoky floaters originate from a retinal or vitreous source of bleeding. However, conditions such as severe high blood pressure, blood disorders including sickle cell disease, inflammatory eye disease, and use of blood-thinning medications can contribute to bleeding inside the eye. This is one reason a thorough evaluation includes a review of your medical history and, when appropriate, coordination with your primary care physician. Identifying and treating any contributing systemic condition helps reduce the risk of future hemorrhage.
Common floaters caused by normal vitreous aging appear as transparent, gray, or web-like shapes that drift slowly across your field of view and are generally more visible against a bright background. They are caused by collagen fibers clumping in the vitreous gel and do not involve bleeding. Dark or smoky floaters, by contrast, appear dense, may look like a moving cloud or curtain of smoke, and often come with a noticeable reduction in visual clarity. This darker, denser quality reflects the presence of blood cells in the vitreous casting shadows on the retina, and it is what distinguishes a potentially serious symptom from a benign one.
Schedule an Evaluation at Atlantic Retina Center
If you are experiencing dark, smoke-like, or cloud-like floaters, please do not wait to be seen. Atlantic Retina Center is a single-specialty vitreoretinal practice serving the Eastern Shore of Maryland and central and southern Delaware, with a team of fellowship-trained, board-certified retina specialists who treat conditions like these every day. We have the advanced imaging and surgical capabilities needed to identify the cause, protect your retina, and guide you through the right course of treatment.